Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jan 27, 2024; 16(1): 59-66
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.59
Table 1 General information
Indicators
Control group (n = 20)
Research group (n = 22)
χ2/t
P value
Age37.20 ± 8.7636.68 ± 10.610.1720.864
Sex0.8770.349
Male15 (75.00)19 (86.36)
Female5 (25.00)3 (13.64)
Course of disease (h)6.00 ± 2.496.82 ± 2.72
BMI (kg/m2)21.76 ± 2.5422.58 ± 2.68
Intra-abdominal hypertension0.4790.787
I12 (60.00)13 (59.09)
II5 (25.00)7 (31.82)
III3 (15.00)2 (9.09)
Types of pancreatitis0.5570.757
Hyperlipidemic pancreatitis16 (80.00)18 (81.82)
Biliary3 (150.00)2 (9.09)
Alcoholic1 (5.00)2 (9.09)
Table 2 Efficacy of the two groups
Indicators
Control group (n = 20)
Research group (n = 22)
χ2
P value
Cure8 (40.00)12 (54.55)
Improvement5 (25.00)8 (36.36)
Ineffectiveness7 (35.00)2 (9.09)
Effective rate13 (65.00)20 (90.91)4.1770.041
Table 3 Safety of the two groups
Indicators
Control group (n = 20)
Research group (n = 22)
χ2
P value
Pancreatic fistula3 (15.00)1 (4.55)
Intra-abdominal hemorrhage3 (15.00)2 (9.09)
Sepsis2 (10.00)1 (4.55)
Organ dysfunction syndrome3 (15.00)1 (4.55)
Total11 (55.00)5 (22.73)4.6270.032